2000
Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans.
Varrone A, Fujita M, Verhoeff NP, Zoghbi SS, Baldwin RM, Rajeevan N, Charney DS, Seibyl JP, Innis RB. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans. Journal Of Nuclear Medicine 2000, 41: 1343-51. PMID: 10945525.Peer-Reviewed Original ResearchConceptsTest-retest variabilityTemporal cortexTest-retest reproducibilityOutcome measuresExtrastriatal regionsD2 receptorsPlasma clearanceExtrastriatal dopamine D2 receptorsGood test-retest variabilityConstant infusion paradigmExtrastriatal D2 receptorsDopamine D2 receptorsBrain radioactivityStriatal radioactivityHealthy volunteersReceptor densityInfusion rateParent tracerSPECT studiesLess test-retest variabilityCortexHigh test-retest variabilityFree fractionReceptor quantificationReceptors
1999
Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT.
Ichise M, Fujita M, Seibyl JP, Verhoeff NP, Baldwin RM, Zoghbi SS, Rajeevan N, Charney DS, Innis RB. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT. Journal Of Nuclear Medicine 1999, 40: 1902-12. PMID: 10565788.Peer-Reviewed Original ResearchConceptsSignificant intersubject variabilityD2 receptorsBlood dataDistribution volumeExtrastriatal dopamine D2 receptorsIntersubject variabilityExtrastriatal D2 receptorsDopamine D2 receptorsSingle blood samplingReceptor-containing regionsNondisplaceable compartmentNondisplaceable distribution volumeHealthy volunteersBlood samplingD2 bindingSPECT studiesTissue ratioPlasma samplesPresence of metabolitesMultilinear regression analysisRegression analysisStriatalReceptorsMetabolite activityLipophilic metabolites